Tammi Gaskins is the Senior Vice President and Chief Commercial Officer at Ironwood Pharmaceuticals Inc. (Class A), a biopharmaceutical company focused on advancing therapies for gastrointestinal diseases. In this pivotal role, she oversees all commercial functions, including sales, marketing, market access, and trade, driving the strategic growth of Ironwood's flagship product, LINZESS, and expanding the company's presence in the U.S. and global markets. Gaskins brings more than 25 years of pharmaceutical industry expertise, with a deep specialization in gastroenterology, rare diseases, and immunology. Her career trajectory includes senior leadership positions at AbbVie, where she served as Vice President of U.S. Gastroenterology, leading the commercial launch of RINVOQ and achieving over $2 billion in peak annual sales within three years. Previously, at Takeda Pharmaceuticals, she directed the Immunology franchise, growing market share by 40% through innovative go-to-market strategies and payer negotiations. Gaskins holds a Bachelor of Science in Biology from the University of North Carolina and an MBA from Duke University’s Fuqua School of Business, complementing her strategic acumen with scientific rigor. Since joining Ironwood in 2022, Gaskins has accelerated LINZESS net product sales to exceed $1 billion annually, forging key partnerships with AbbVie and optimizing reimbursement strategies to improve patient access. Her leadership has positioned Ironwood for sustained growth, earning her recognition as a top executive in pharmaceutical commercialization by Fierce Pharma and PharmaVOICE.